Bearish
Vera Therapeutics (VERA) CEO sells 18,500 shares under 10b5-1 plan
Vera Therapeutics (VERA) CEO Marshall Fordyce sold a total of 18,500 shares of Class A Common Stock on June 23, 2026, under a pre-arranged Rule 10b5-1...